Champions Oncology, Inc. ( CSBR) - Stock Earnings
CSBR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -279000 USD | 16.6 million USD |
| 2026Q1 | -729000 USD | 13.8 million USD |
| 2026Q2 | -426000 USD | 15.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CSBR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -7.3 million USD | 50.2 million USD |
| 2025 | 4.7 million USD | 56.9 million USD |
| 2026 | -1.2 million USD | 59.4 million USD |
| 2026 Est. | — | — |
CSBR
Price: $4.81
52 week price:
Earnings Per Share: -0.08 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4300
Ebitda: -4.7 millionMarket Capitalization: 68.6 million